Stryker Corp.

SYK-N

NYSE:SYK

182.72
6.29 (3.57%)
Stryker Corporation is a Fortune 500 medical technologies firm based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and ...
More at Wikipedia

Analysis and Opinions about SYK-N

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
April 7, 2020

Likes it. He hasn't bought it, because he isn't sure which stock to own in this sector. Abbott and Boston Scientific are better choices, he thinks, with more upside potential given product innovation.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 7, 2020

Likes it. He hasn't bought it, because he isn't sure which stock to own in this sector. Abbott and Boston Scientific are better choices, he thinks, with more upside potential given product innovation.

PAST TOP PICK
PAST TOP PICK
March 12, 2020
(A Top Pick May 21/19, Down 16%) Medical devices, which is very strong. It's a practical way to keep people out of hospitals. Great story about demographics.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
March 12, 2020
(A Top Pick May 21/19, Down 16%) Medical devices, which is very strong. It's a practical way to keep people out of hospitals. Great story about demographics.
BUY WEAKNESS
BUY WEAKNESS
February 26, 2020

A great medical equipment company. Over time, they've consolidated and grown. Demographic trends are on his side. But he owns Abbott instead; you can't own everything. Wait for more of a pullback to buy. If the PE falls to the low-$20s, step in.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 26, 2020

A great medical equipment company. Over time, they've consolidated and grown. Demographic trends are on his side. But he owns Abbott instead; you can't own everything. Wait for more of a pullback to buy. If the PE falls to the low-$20s, step in.

TOP PICK
TOP PICK
February 21, 2020

A manufacturer of medical and surgical devices. The company has had positive sales growth for over 40 years. They do a great job at identifying areas where they are weak, finding a way to fill that gap and executing the strategy quickly. There is not much exposure they hold in China -- fortuitous right now. Yield 1.03% (Analysts’ price target is $232.92)

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 21, 2020

A manufacturer of medical and surgical devices. The company has had positive sales growth for over 40 years. They do a great job at identifying areas where they are weak, finding a way to fill that gap and executing the strategy quickly. There is not much exposure they hold in China -- fortuitous right now. Yield 1.03% (Analysts’ price target is $232.92)

TOP PICK
TOP PICK
February 18, 2020
A good acquirer and integrator and have a good position in hip and knee replacement. They're aiming for 1,000 robotic installations worldwide, now at 850. They took a drop in their last purchase but they've bounced back. (Analysts’ price target is $232.92)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 18, 2020
A good acquirer and integrator and have a good position in hip and knee replacement. They're aiming for 1,000 robotic installations worldwide, now at 850. They took a drop in their last purchase but they've bounced back. (Analysts’ price target is $232.92)
COMMENT
COMMENT
February 14, 2020

Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 14, 2020

Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.

BUY
BUY
February 11, 2020
Medical devices are a good play on aging US demographics. SYK recently merged with a smaller company to consolidate their hips and knees products. He owns its peers including Boston Scientific, but the whole space is enjoying a nice upside. You can buy SYK.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 11, 2020
Medical devices are a good play on aging US demographics. SYK recently merged with a smaller company to consolidate their hips and knees products. He owns its peers including Boston Scientific, but the whole space is enjoying a nice upside. You can buy SYK.
BUY
BUY
February 6, 2020
Joint replacements. Medical instruments. Great company. Issues with latest acquisition, so stock fell below its high.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 6, 2020
Joint replacements. Medical instruments. Great company. Issues with latest acquisition, so stock fell below its high.
COMMENT
COMMENT
January 29, 2020

SYK vs. Anthem He likes both. Stryker trades at 23x PE. He owns Anthem, which hit on earnings, but the market was skittish on their expense line. It's a great healthcare company

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 29, 2020

SYK vs. Anthem He likes both. Stryker trades at 23x PE. He owns Anthem, which hit on earnings, but the market was skittish on their expense line. It's a great healthcare company

PAST TOP PICK
PAST TOP PICK
January 20, 2020
(A Top Pick Jan 04/19, Up 21%) The best, most innovative medical device company around. It's come off its highs recently as it acquired a spinal business, but it has room to run. It's long grown its earnings for many years. They excel at buying small companies specializing in hips, knees and spines.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 20, 2020
(A Top Pick Jan 04/19, Up 21%) The best, most innovative medical device company around. It's come off its highs recently as it acquired a spinal business, but it has room to run. It's long grown its earnings for many years. They excel at buying small companies specializing in hips, knees and spines.
TOP PICK
TOP PICK
January 17, 2020
A diversified medical devices company. They create a variety of equipment, including orthopaedics and robotic surgery. The company has executed very well. They recently made an acquisition that helps them move into hips, knees and ankles. There is volatility. He would enter around $205-210. (Analysts’ price target is $230.25)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 17, 2020
A diversified medical devices company. They create a variety of equipment, including orthopaedics and robotic surgery. The company has executed very well. They recently made an acquisition that helps them move into hips, knees and ankles. There is volatility. He would enter around $205-210. (Analysts’ price target is $230.25)
TOP PICK
TOP PICK
December 19, 2019
Good demographic growth--people are getting older and need hip and knee replacement. They just bought a company that will make SYK the biggest company serving hands and ankles. Another plus is that doctors tend to stick with the same medical product manufacturers. They have $3 billion in free cash and pays a nice dividend. They constantly buy companies, but their debt is fine. (Analysts’ price target is $231.08)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
December 19, 2019
Good demographic growth--people are getting older and need hip and knee replacement. They just bought a company that will make SYK the biggest company serving hands and ankles. Another plus is that doctors tend to stick with the same medical product manufacturers. They have $3 billion in free cash and pays a nice dividend. They constantly buy companies, but their debt is fine. (Analysts’ price target is $231.08)
DON'T BUY
DON'T BUY
December 18, 2019

SYK vs. JNJ SYK makes medical products while JNJ also produces that plus pharma and personal care products, but are fighting talcum powder lawsuits that will persist. Despite this, he much prefers JNJ due to better diversification and valuation. But wait for a better entry point.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
December 18, 2019

SYK vs. JNJ SYK makes medical products while JNJ also produces that plus pharma and personal care products, but are fighting talcum powder lawsuits that will persist. Despite this, he much prefers JNJ due to better diversification and valuation. But wait for a better entry point.

BUY
BUY
November 27, 2019
Diversified in orthopedics and medical instruments. Zimmer falling on hard times has been to its benefit. Not that expensive, around 20x earnings. Likes it.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 27, 2019
Diversified in orthopedics and medical instruments. Zimmer falling on hard times has been to its benefit. Not that expensive, around 20x earnings. Likes it.
PAST TOP PICK
PAST TOP PICK
November 7, 2019
(A Top Pick Nov 20/18, Up 22%) Demographically, in a great spot. Recent acquisition will expand their market. Developing robotics. Positive long-term.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 7, 2019
(A Top Pick Nov 20/18, Up 22%) Demographically, in a great spot. Recent acquisition will expand their market. Developing robotics. Positive long-term.
Showing 1 to 15 of 86 entries

Stryker Corp.(SYK-N) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 14

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 2

Total Signals / Votes : 16

Stockchase rating for Stryker Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Stryker Corp.(SYK-N) Frequently Asked Questions

What is Stryker Corp. stock symbol?

Stryker Corp. is a American stock, trading under the symbol SYK-N on the New York Stock Exchange (SYK). It is usually referred to as NYSE:SYK or SYK-N

Is Stryker Corp. a buy or a sell?

In the last year, 16 stock analysts published opinions about SYK-N. 14 analysts recommended to BUY the stock. 2 analyst recommended to SELL the stock. The latest stock analyst recommendation is DON'T BUY. Read the latest stock experts' ratings for Stryker Corp..

Is Stryker Corp. a good investment or a top pick?

Stryker Corp. was recommended as a Top Pick by David Fingold on 2020-04-07. Read the latest stock experts ratings for Stryker Corp..

Why is Stryker Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Stryker Corp. worth watching?

16 stock analysts on Stockchase covered Stryker Corp. In the last year. It is a trending stock that is worth watching.

What is Stryker Corp. stock price?

On 2020-04-09, Stryker Corp. (SYK-N) stock closed at a price of $182.72.